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The initial Regent valve implanted in
these 3 cases was likely oversized and the
pivot guard not seated properly. In each
case, the Regent valve was replaced with a
valve of a smaller effective tissue annulus
diameter (ETAD) compared with the St
Jude Medical standard model and a smaller
effective orifice area (EOA) determined
from industry-provided data.4,5 In case 1, a
25-mm tissue annulus diameter (TAD) St
Jude Medical Regent valve (TAD 25 mm,
ETAD 28 mm, EOA 2.6 cm2) was replaced
with a 23 mm Regent valve (TAD 23 mm,
ETAD 26 mm, EOA 2.5 cm2). In case 2, a
27-mm Regent valve (TAD 27 mm, ETAD
30 mm, EOA 3.5 cm2) was replaced with a
27-mm CarboMedics standard valve (Sul-
zer Carbomedics, Inc, Austin, Tex) (TAD
27 mm, ETAD 27 mm, EOA 2.2 cm2). In
the third case, a 25-mm Regent valve was
replaced with a 25-mm CarboMedics stan-
dard valve (TAD 25 mm, ETAD 25 mm,
EOA 1.5 cm2); again a smaller valve by
ETAD with a markedly smaller EOA. Su-
ture technique may have compounded the
oversizing. The high EOA in all Regent
valves makes oversizing unnecessary.6 The
calculations of Pibarot and associates7 for
patient-prosthesis mismatch indicate only 1
patient (case 3), after a 25-mm CarboMed-
ics valve implant was at risk for mismatch
(EOA 1.5 cm2, EOAI 0.6 cm2/mm2).
In summary, the problems Øvrum and
Tangen encountered can be explained by
implantation techniques, depth of sutures,
and oversizing of the Regent valve rather
than by the valve itself.
Robert W. Emery, MD
Cardiac Surgical Associates, PA
Minneapolis, MN 55407
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Reply to the Editor:
We appreciate the interest in our brief re-
port1 regarding acute leaflet arrest in the St
Jude Medical (SJM) Regent aortic valve
(St Jude Medical, Inc, St Paul, Minn). The
remarks forwarded by Dr Emery clearly
indicate that specific precautions must be
taken regarding the technique of implanta-
tion. His figure 1 demonstrates the shorter
distance from the subvalvular tissue to the
hinges. He proposes everting mattress su-
tures for inserting all the types of SJM
valves, and this is certainly a safe tech-
nique. However, we are not convinced that
this is the most common procedure for im-
plantation of supra-annular prostheses. To
our knowledge, the most preferred tech-
nique is ventricular-to-aortic sutures for su-
pra-annular valves, to optimize the orifice
area.
These circumstances were the main rea-
son for our publication. We used standard
and widely recognized suture techniques
for aortic valve replacement, and severe
technical problems occurred with the SJM
Regent valve. The reported cases were rou-
tine operations without any particular dif-
ficulties from the patient’s side. After the
valve was tied down, the leaflets were un-
movable and rotation was impossible, due
to entrapment of the subvalvular tissue into
the hinges. The operations were performed
by senior cardiac surgeons, having im-
planted a large number of several types of
aortic valve prostheses during more than 25
years. The situation was most unpleasant,
particularly considering the potential risk
of pledget escape when cutting the sutures
for removal of the valve. All patients had
an uneventful recovery after a prolonged
operation for rereplacement. However,
similar negative experience has not been
published with other valves, and therefore
we wanted to share our experience with
other surgeon colleagues.
We do not believe that oversizing was
the case in any of the patients. They were
all adult male patients with normal size of
the aortic ostia and candidates for 25-mm
to 27-mm valves. If the SJM Regent valve
has to be downsized on routine basis, the
hemodymamic advantages must, at least
partly, be abolished. 1
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I read “Mechanical Aortic Valve Malfunc-
tion: An Intraoperative BioGlue Complica-
tion” by Karimi and associates. The com-
munication reports that BioGlue (Cryolife
Inc, Kennesaw, Ga) can migrate through
the aortotomy suture line. It was interesting
that there was an interval after the glue was
applied to the suture line but before it mi-
grated through to cause the mechanical
valve incompetence (demonstrated by the
altered function of the prosthetic valve on
transesophageal echocardiography). Also
of concern was the fact that the BioGlue
migrated through 4-0 suture holes rather
than a defect in the aortotomy closure.
I recently performed repair of a type I
aortic dissection with ascending aorta and
hemic-arch replacement and with resuspen-
sion of the aortic valve. The patient had
been treated with heparin, clopidogrel, and
aspirin after admission because of an as-
sumed diagnosis of myocardial infarction.
After the patient was separated from cardio-
pulmonary bypass, with protamine, fresh-
frozen plasma, and platelets having been
administered, there was still oozing from
the suture line. A thin layer of BioGlue was
applied, with cessation of the bleeding. The
patient had a cardiac output of 7 L and
excellent intraoperative myocardial func-
tion.
Forty-five minutes after return to the
intensive care unit, the patient became hy-
potensive, with a 1-mm increase of the
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